Literature DB >> 24955047

What is new in the 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic risk in adults?

Salim S Virani1.   

Abstract

Entities:  

Keywords:  Arterial disease, peripheral; atherosclerosis; cholesterol, low-density-lipoprotein; cholesterol, non-high-density-lipoprotein; guidelines, cholesterol-management; hypercholesterolemia; risk calculator; statin therapy, long-term; statins, use of

Mesh：

Substances：

Year:  2014        PMID： 24955047      PMCID： PMC4060334          DOI： 10.14503/THIJ-13-4077

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN： 0730-2347


× No keyword cloud information.
  3 in total

1.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

2.  Refocusing the agenda on cardiovascular guidelines: an announcement from the National Heart, Lung, and Blood Institute.

Authors:  Gary H Gibbons; Susan B Shurin; George A Mensah; Michael S Lauer
Journal:  J Am Coll Cardiol       Date:  2013-10-08       Impact factor: 24.094

3.  2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  Neil J Stone; Jennifer G Robinson; Alice H Lichtenstein; C Noel Bairey Merz; Conrad B Blum; Robert H Eckel; Anne C Goldberg; David Gordon; Daniel Levy; Donald M Lloyd-Jones; Patrick McBride; J Sanford Schwartz; Susan T Shero; Sidney C Smith; Karol Watson; Peter W F Wilson
Journal:  J Am Coll Cardiol       Date:  2013-11-12       Impact factor: 24.094
  3 in total
  2 in total

Review 1.  The role of antisense oligonucleotide therapy in patients with familial hypercholesterolemia: risks, benefits, and management recommendations.

Authors:  Anandita Agarwala; Peter Jones; Vijay Nambi
Journal:  Curr Atheroscler Rep       Date:  2015-01       Impact factor: 5.113

2.  The Cost-Benefit Balance of Statins in Hawai'i: A Moving Target.

Authors:  Corey J Lum; Kazuma Nakagawa; Ralph V Shohet; Todd B Seto; Deborah A Taira
Journal:  Hawaii J Med Public Health       Date:  2017-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.